Table 2 Multivariable regression analyses of potential clinical factors associated with the intra-patient temporal instability of the oral and stool microbiomes of AML patients

Age

0.287

0.864

0.529

0.425

0.779

0.885

Received piperacillin/tazobactam >72 h

0.475

0.208

0.175

0.507

0.215

0.973

Received cefepime >72 h

0.108

0.557

0.943

0.508

0.669

0.639

Received carbapenem >72 h

0.748

0.762

0.832

0.360

0.482

0.681

Days on all antibiotics^a

0.031^b

0.0001^b

0.002^b

0.392

0.858

0.580

Days on treatment antibiotics

0.205

0.060

0.163

0.917

0.633

0.451

Number of antibiotics received

0.089

0.380

0.874

0.357

0.724

0.167

Non-fludarabine high intensity chemotherapy

0.723

0.581

0.935

0.415

0.605

0.456

Hypomethylator-based chemotherapy

0.734

0.712

0.181

0.244

0.900

0.612